Key result
Improving HF self-management programs requires advanced translational research to boost clinical translation and cost-effectiveness.
Why the study?
While therapeutics for congestive heart failure have advanced through large trials, chronic disease self-management has lagged and its evidence base has been questioned.
Advancing translational research standards and understanding evidence generation is important to achieve optimal cost-effectiveness for chronic disease self-management in heart failure.
Answers are grounded in this paper and cite their sources.
Without advanced standards, HF self-management programs may lack cost-effectiveness; leaves open optimal mixed-method translational designs.
BACKGROUND: Congestive heart failure (CHF) management has proven devastating on morbidity, mortality, quality of life and also costly to health systems. Therapeutics for CHF have advanced and benefited greatly due to large multicentre randomised controlled trials and the evidence obtained from them. Management for chronic diseases and nonpharmaceutical therapies such as chronic disease self-management has lagged, and for CHF the evidence base has even been questioned. METHODS: Perspective and non systematic mini review. CONCLUSIONS: Advancing translational research standards is important to achieve optimal cost effectiveness. Importantly is understanding evidence generation in medicine, identifying the primary roots for management and its translation.
No takes yet. Share an insight, caveat, or question.
Iyngkaran et al. (2022) conducted a review in Congestive heart failure. Chronic disease self-management was evaluated. Advancing translational research standards and mixed-method approaches are needed to improve the clinical translation and cost-effectiveness of chronic disease self-management programs for heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: